3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
3
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
14
Radiotherapy
13
Oxaliplatin
8
Fluorouracil
7
Gemcitabine
6
Drug Therapy
6
Leucovorin
5
Doxorubicin
5
Cytarabine
5
Cyclophosphamide
5
Carboplatin
5
Capecitabine
5
durvalumab
4
Paclitaxel
4
Etoposide
4
Docetaxel
4
Chemotherapy, Adjuvant
4
Biological Therapy
4
bicalutamide
3
Rituximab
3
Radiotherapy, Intensity-Modulated
3
Polymerase Chain Reaction
3
Platinum
3
Peripheral Blood Stem Cell Transplantation
3
Methylprednisolone
3
Gene Expression Profiling
3
Dexamethasone
3
Bortezomib
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
NETWORK
×
sotorasib
×
Clear all
NCT06068153
2024-11-20
AMBER
ETOP IBCSG Partners Foundation
Phase 2
Withdrawn